Rates and reasons for device-based guideline eligibility in patients with heart failure

Kristin J Lyons1, Mohua Podder2, Justin A Ezekowitz3

  • 1Division of Cardiology, Department of Medicine; Mazankowski Alberta Heart Institute.

Heart Rhythm
|August 8, 2014
PubMed

Insights

Device therapy adherence for heart failure (HF) patients is higher than previously estimated. Accounting for patient preferences reveals improved rates for implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT).

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) are guideline-recommended for heart failure (HF) patients.
  • Estimates of device eligibility and utilization are uncertain, partly due to how guideline nonadherence is assessed.

Purpose of the Study:

  • To determine guideline eligibility and device utilization rates for ICD and CRT.
  • To account for documented reasons for not receiving these devices.

Main Methods:

  • Retrospective chart review of 762 heart failure patients (2006-2011) at a Canadian tertiary Heart Function Clinic.
  • Data collected included factors for guideline eligibility and reasons for nonadherence.

Main Results:

  • 57% of patients were guideline-eligible for a device; 43% were never eligible.
  • Adherence rates for eligible patients were 59-68% (ICD) and 66-81% (CRT).
  • After excluding nonadherence reasons, adherence in "truly eligible" patients was higher (70-81% ICD, 71-88% CRT). Patient preference was a key reason for nonadherence.

Conclusions:

  • Device therapy utilization in HF patients is likely higher than prior registry estimates suggest.
  • Patient preferences significantly impact device use and should be considered in quality metrics.
  • Future quality-of-care metrics need detailed chart data and patient preference information.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
617
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
861
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
630
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
782
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.5K